International Validation of a Bladder Screening Tool for Overactive Bladder

Cardozo L1, Noblett K2, Staskin D3, Degboe A4, Chen W5, Currie B5, Wiklund I5, Globe D4, Dmochowski R6, Signori M7, MacDiarmid S8, Nitti V9

Abstract Category

Epidemiology & Outcomes Research

Abstract 491
Non Discussion Poster
Scientific Non Discussion Poster Session 34
Incontinence Overactive Bladder Urgency Urinary Incontinence
1. King's College Hospital, London, UK, 2. UC Irvine Medical Center, Irvine, CA, USA, 3. Tufts University School of Medicine, Boston, MA, USA, 4. Allergan, Global Health Outcomes Strategy and Research, Irvine, CA, USA, 5. United BioSource Corporation, Outcomes Research, Bethesda, MD, USA, 6. Vanderbilt University, Nashville, TN, USA, 7. Allergan, Global Strategic Marketing, Irvine, CA, USA, 8. Alliance Urology, Greensboro, SC, USA, 9. New York University School of Medicine, New York, NY, USA
Links

Abstract